ATE302013T1 - Azithromycin enthaltende zusammensetzungen zur kontrolle von emesis bei hunden - Google Patents

Azithromycin enthaltende zusammensetzungen zur kontrolle von emesis bei hunden

Info

Publication number
ATE302013T1
ATE302013T1 AT99309405T AT99309405T ATE302013T1 AT E302013 T1 ATE302013 T1 AT E302013T1 AT 99309405 T AT99309405 T AT 99309405T AT 99309405 T AT99309405 T AT 99309405T AT E302013 T1 ATE302013 T1 AT E302013T1
Authority
AT
Austria
Prior art keywords
dogs
compositions containing
macrolide antibiotic
containing azithromycin
antagonist
Prior art date
Application number
AT99309405T
Other languages
English (en)
Inventor
Richard Todd Darrington
Dennis Michael Godek
Elizabeth Leigh Fraerin Illyes
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of ATE302013T1 publication Critical patent/ATE302013T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Fodder In General (AREA)
AT99309405T 1999-01-29 1999-11-25 Azithromycin enthaltende zusammensetzungen zur kontrolle von emesis bei hunden ATE302013T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11787699P 1999-01-29 1999-01-29

Publications (1)

Publication Number Publication Date
ATE302013T1 true ATE302013T1 (de) 2005-09-15

Family

ID=22375307

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99309405T ATE302013T1 (de) 1999-01-29 1999-11-25 Azithromycin enthaltende zusammensetzungen zur kontrolle von emesis bei hunden

Country Status (12)

Country Link
US (3) US20020016301A1 (de)
EP (1) EP1027892B1 (de)
JP (1) JP2000219640A (de)
KR (1) KR20000052444A (de)
AT (1) ATE302013T1 (de)
AU (1) AU6065799A (de)
CA (1) CA2290771A1 (de)
DE (1) DE69926722D1 (de)
HU (1) HUP9904393A2 (de)
IL (1) IL133077A0 (de)
NZ (1) NZ501211A (de)
ZA (1) ZA997288B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20030011797A (ko) * 2000-03-28 2003-02-11 바이오케미 게젤샤프트 엠베하 맛이 차폐된 과립형 입자
GB0315671D0 (en) * 2003-07-04 2003-08-13 Chelsea And Westminster Nhs Tr Improvements in or relating to organic compounds
EP2029147B1 (de) * 2006-06-12 2010-05-19 Ramot at Tel-Aviv University Ltd. Verfahren zur behandlung von krebs
WO2010031054A1 (en) 2008-09-15 2010-03-18 Biovista, Inc. Compositions and methods for treating epilepsy
WO2012082992A1 (en) * 2010-12-15 2012-06-21 Biovista, Inc. Compositions and methods for cancer treatment
WO2013130422A1 (en) 2012-02-27 2013-09-06 Biovista, Inc. Compositions and methods for treating mitochondrial diseases
KR20230155155A (ko) * 2022-05-03 2023-11-10 녹십자수의약품 주식회사 마크로라이드 계열 항생제를 유효성분으로 포함하는 개과 동물의 호흡기 질환의 예방 또는 치료용 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63107994A (ja) * 1986-05-02 1988-05-12 Taisho Pharmaceut Co Ltd エリスロマイシン誘導体
EP1082959A1 (de) * 1991-09-20 2001-03-14 Glaxo Group Limited NK1 Antagonisten zur Behandlung von Depression
MX9308001A (es) * 1992-12-21 1994-08-31 Lilly Co Eli Premezcla para piensos de animales que contiene tilosina y procedimiento para su obtencion.
GB9305718D0 (en) * 1993-03-19 1993-05-05 Glaxo Group Ltd Medicaments
US5393762A (en) * 1993-06-04 1995-02-28 Pfizer Inc. Pharmaceutical agents for treatment of emesis
FR2740335B1 (fr) * 1995-10-26 1997-12-19 Oreal Utilisation de sel de lanthanide, de lithium, d'etain, de zinc, de manganese ou d'yttrium comme antagoniste de substance p
CA2189501A1 (en) * 1995-11-06 1997-05-07 Harry R. Howard Nk-1 receptor antagonists for the treatment of cancer
US5958888A (en) * 1996-07-02 1999-09-28 Merial, Inc. Water miscible macrolide solutions

Also Published As

Publication number Publication date
ZA997288B (en) 2001-05-24
US20020016301A1 (en) 2002-02-07
US20030018049A1 (en) 2003-01-23
KR20000052444A (ko) 2000-08-25
JP2000219640A (ja) 2000-08-08
DE69926722D1 (de) 2005-09-22
CA2290771A1 (en) 2000-07-29
US20040063649A1 (en) 2004-04-01
EP1027892B1 (de) 2005-08-17
IL133077A0 (en) 2001-03-19
HU9904393D0 (en) 2000-01-28
EP1027892A3 (de) 2002-06-19
AU6065799A (en) 2000-08-03
NZ501211A (en) 2001-10-26
EP1027892A2 (de) 2000-08-16
HUP9904393A2 (en) 2002-09-28

Similar Documents

Publication Publication Date Title
BR9714269A (pt) Composto, composição farmacêutica, e, processos para controlar uma infecção bacteriana em um mamìfero e para a preparação de compostos macrólidos tricìclicos
KR0145958B1 (en) Antibacterial agents
GEP20053429B (en) 3-Aminoquinazolin-2,4-Dione, Pharmaceutical Composition Containing Them and Use Thereof as Antibacterial Agents
PT806941E (pt) Composicoes anti-bacterianas liposomicas de rigidez baixa
MY131300A (en) Antibacterial agents
ATE161265T1 (de) Derivate von 16-gliedrigen antibiotischen macroliden
RU94020410A (ru) Способ лечения или профилактики рвоты у млекопитающих и человека с использованием некоторых хинуклидиновых, пиперидиновых, азанорборнановых, этилендиаминовых производных и родственных им соединений
DE69926722D1 (de) Azithromycin enthaltende Zusammensetzungen zur Kontrolle von Emesis bei Hunden
MX9708611A (es) Compuestos de dialquiltiacumicina.
HU9403502D0 (en) 9 a-n-(n`-carbamoyl) and 9 a-n-(n`-thiocarbamoyl) derivatives 9-deoxo-9a-aza-9a-homoerythro-mycin a
MD1788G2 (ro) Derivaţi de 9-O-oximă ai Eritromicinei A, compoziţie farmaceutică pe baza lor şi metodă de tratament al bolilor infecţioase
DK0560613T3 (da) Antimikrobielle carbapenemderivater, deres fremstilling og deres terapeutiske anvendelse
FI101978B1 (fi) Menetelmä leustroduksiinien valmistamiseksi
BR9708864A (pt) Composto composição farmacêutica e processo para o tratamento ou a prevenção de uma infecção bacteriana em um paciente mamífero
DE3775823D1 (de) Pharmazeutische zubereitung zur behandlung bakterieller infektionen.
BR0308734A (pt) Composto, composição farmacêutica, uso do composto, e, método para prevenir ou tratar infecção
NO20042711L (no) Fremgangsmate for a behandle bakterielle infeksjoner ved anvendelse av gemifloksasin eller et salt derav et betalaktamantibiotikum
ES8707955A1 (es) Un procedimiento para la preparacion pirazolidinonas biciclicas'
DE69024141D1 (de) Chemische Derivate von Antbiotika LL-E19020 alpha und beta
TR199701286T1 (xx) Karbapenemlerin esterleri.
ATE231878T1 (de) 3-deoxy-3-descladinosederivate von erythromycin a und b
IL83626A (en) Macrolide antibiotic, swalpamycin, a microbiological process for its preparation and pharmaceutical compositions containing same
ZA901320B (en) Compositions for the treatment of microbial infections
UA22243A (uk) Спосіб лікуваhhя локальhих гhійhо-запальhих захворюваhь
ES2106560T3 (es) Antibioticos 10381v, w, x, y, z1, z2, pre-b y t.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties